《Slas Discovery》雜志的最新年發(fā)文量為50篇。
這表明該刊在每年都會(huì)精選并發(fā)表一定數(shù)量的高質(zhì)量文章,以保持其在生化研究方法領(lǐng)域的學(xué)術(shù)影響力。
該刊聚焦于生物學(xué)-生化研究方法領(lǐng)域的前沿研究,致力于推動(dòng)該領(lǐng)域新技術(shù)和新知識(shí)的傳播與應(yīng)用。同時(shí)它積極鼓勵(lì)研究人員詳細(xì)發(fā)表其高質(zhì)量的實(shí)驗(yàn)研究和理論成果。
該刊的平均審稿周期約為 12 Weeks 。
Slas Discovery 雜志發(fā)文統(tǒng)計(jì)
文章名稱引用次數(shù)
- Spontaneous Glioblastoma Spheroid Infiltration of Early-Stage Cerebral Organoids Models Brain Tumor Invasion17
- Advanced Development of Primary Pancreatic Organoid Tumor Models for High-Throughput Phenotypic Drug Screening17
- 3D Cell-Based Assays for Drug Screens: Challenges in Imaging, Image Analysis, and High-Content Analysis16
- OCTN: A Small Transporter Subfamily with Great Relevance to Human Pathophysiology, Drug Discovery, and Diagnostics14
- Transfer Learning with Deep Convolutional Neural Networks for Classifying Cellular Morphological Changes13
- Clinical Trials in a Dish: A Perspective on the Coming Revolution in Drug Development12
- Use of a High-Throughput Phenotypic Screening Strategy to Identify Amplifiers, a Novel Pharmacological Class of Small Molecules That Exhibit Functional Synergy with Potentiators and Correctors11
- Screening Approaches for Targeting Ribonucleoprotein Complexes: A New Dimension for Drug Discovery11
- Discovery of a Selective Inhibitor for the YEATS Domains of ENL/AF910
- Positioning High-Throughput CETSA in Early Drug Discovery through Screening against B-Raf and PARP110
國家/地區(qū)發(fā)文量
- USA180
- England49
- GERMANY (FED REP GER)25
- Sweden17
- Canada15
- Italy15
- Japan15
- CHINA MAINLAND12
- Switzerland12
- France11